Come finish out the year with some of the best in biotech reporting. Join STAT’s Adam Feuerstein, Rebecca Robbins, and Damian Garde as they preview the trends, clinical trial readouts, and M&A shakeups they’re expecting to see in 2019. First up — what’s coming at January’s J.P. Morgan Healthcare Conference.

Bring questions, and a guest or two. The panel discussion begins at 6:30 p.m., and beverages and light hors d’oeuvres will be provided.

This event is only available for STAT Plus subscribers. Subscribe today to attend — plus enjoy 10% off with the code INVEST10. Already a subscriber? Log in to save a seat.

GET STARTED

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy